Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Zaleplon

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,067Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taiwan bans four types of sleeping pills for certain patients
    Taiwan bans four types of sleeping pills for certain patients

    28 Apr 2020

    // Sophia Yang TAIWANNEWS

    https://www.taiwannews.com.tw/en/news/3924427

    Sophia Yang TAIWANNEWS
    28 Apr 2020
    Share Share
    Sleeping Pills Get Black Box Warning Following Accidental Deaths
    Sleeping Pills Get Black Box Warning Following Accidental Deaths

    16 May 2019

    // ORGANICCONSUMER

    https://www.organicconsumers.org/news/sleeping-pills-get-black-box-warning-following-accidental-deaths

    ORGANICCONSUMER
    16 May 2019
    Share Share
    FDA requires stronger warnings about rare serious incidents insomnia medicines
    FDA requires stronger warnings about rare serious incidents insomnia medicines

    01 May 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-requires-stronger-warnings-about-rare-but-serious-incidents-related-to-certain-prescription-insomnia-medicines-300840960.html

    PR NEWSWIRE
    01 May 2019
    Share Share
    FDA Adds Boxed Warnings to Insomnia Medicines Following Injuries, Deaths
    FDA Adds Boxed Warnings to Insomnia Medicines Following Injuries, Deaths

    30 Apr 2019

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/4/fda-adds-boxed-warnings-to-insomnia-medicines-foll

    Zachary Brennan RAPS
    30 Apr 2019
    Share Share
    Upsher-Smith Laboratories; Withdrawal of Approval of an ANDA for ZALEPLON
    Upsher-Smith Laboratories; Withdrawal of Approval of an ANDA for ZALEPLON

    16 Aug 2017

    // FEDERAL REGISTER

    https://www.federalregister.gov/documents/2017/08/16/2017-17301/upsher-smith-laboratories-inc-withdrawal-of-approval-of-an-abbreviated-new-drug-application-for

    FEDERAL REGISTER
    16 Aug 2017
    Share Share
    Intec Pharma Enters into Agreement with the Michael J. Fox Foundation
    Intec Pharma Enters into Agreement with the Michael J. Fox Foundation

    28 Nov 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/intec-pharma-enters-into-agreement-with-the-michael-j-fox-foundation-around-its-phase-iii-trial-recruitment-603359696.html

    PR NEWSWIRE
    28 Nov 2016
    Share Share